• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease Clinical Trials
In conclusion, the decrease in HR with ivabradine was associated with an increase in central systolic pressure, which may have antagonized possible benefits of HR lowering in coronary artery disease patients. Clinical Trials—URL: http://www.clinicaltrials.gov. Unique identifier NCT01039389.
Source: Hypertension - May 10, 2016 Category: Cardiology Authors: Rimoldi, S. F., Messerli, F. H., Cerny, D., Gloekler, S., Traupe, T., Laurent, S., Seiler, C. Tags: Hemodynamics, Hypertension, Coronary Artery Disease Clinical Trials Source Type: research

High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of {beta}-Blockers to Reduce Their Elevated Risk Brief Review
Source: Hypertension - October 7, 2015 Category: Cardiology Authors: Struthers, A. D., George, J. Tags: Cardiovascular Pharmacology, Primary prevention, Cerebrovascular disease/stroke, Other hypertension, Clinical Studies Brief Review Source Type: research

Natriuretic Peptide: A Probable Culprit in Prevention of Primary Cardiovascular Diseases Using {beta}-Blockers Letters to the Editor
Source: Hypertension - March 12, 2014 Category: Cardiology Authors: Peng, H., Liu, Y. Tags: Biochemistry and metabolism, Cerebrovascular disease/stroke, Myocardial cardiomyopathy disease Letters to the Editor Source Type: research